Newcastle Disease Vaccine Market Size, Share, Growth, And Industry Analysis by Type (Live Vaccines, Killed Vaccines) by Application (Chicken, Duck and Goose & Other), Regional Forecast to 2031

Updated On: 22 April 2024

Newcastle Disease Vaccine Market Report Overview

• 

• Request a Free Sample to learn more about this report

global newcastle disease vaccine market size was USD 314.8 million in 2021 and market is projected to touch 436.73 million by 2031, exhibiting a CAGR of 3.3% during the forecast period.

The Newcastle disease vaccine is a crucial preventive measure used to protect poultry and birds from Newcastle disease, caused by a highly contagious virus. The vaccine stimulates the birds' immune system to produce antibodies, which helps fend off the virus upon exposure. It comes in various forms, including live attenuated, inactivated, and recombinant vaccines. Effective vaccination prevents the spread of the disease, reducing mortality rates and economic losses in the poultry industry. Regular vaccination programs are essential to maintain healthy flocks and to safeguard against outbreaks that can have devastating consequences on poultry populations and food security.

The Newcastle disease vaccine market is growing due to several factors contributing to an increasing demand for the product. Firstly, the global population's rising demand for poultry products has led to expanded poultry farming, necessitating increased vaccination to protect against disease outbreaks. Secondly, the awareness of the economic losses caused by Newcastle disease has prompted poultry farmers to adopt proactive preventive measures like vaccination to ensure the health and productivity of their flocks. Additionally, governments and regulatory bodies are encouraging vaccination as a crucial biosecurity measure to control and prevent the spread of the disease, further fueling the demand for Newcastle disease vaccines in the market.

COVID-19 Impact: Due To Supply Chain Disruptions Brought On By The Pandemic, Vaccine Production And Distribution Experienced Shortages And Delays

The COVID-19 pandemic had a significant impact on various markets worldwide, including the Newcastle disease vaccine market. The pandemic disrupted supply chains, leading to shortages and delays in vaccine production and distribution. Governments diverted resources and attention to combatting the virus, which affected vaccine research and development efforts. Furthermore, restrictions and lockdown measures limited the movement of goods and personnel, affecting the availability and accessibility of vaccines in some regions. On the demand side, the focus on human health and safety during the pandemic shifted priorities, leading to potential fluctuations in the uptake of animal vaccines, including Newcastle disease vaccines. Despite these challenges, the pandemic also highlighted the importance of biosecurity measures, potentially reinforcing the need for vaccination to protect against disease outbreaks in the poultry industry.

Latest Trends

"The Creation Of More Cutting-Edge And Effective Vaccination Technology Is One Trend In The Market For Vaccines Against Newcastle Disease"

One trend in the Newcastle disease vaccine market is the development of more advanced and efficient vaccine technologies. Companies are investing in research and innovation to create next-generation vaccines with improved efficacy and reduced side effects. These new products may include recombinant vaccines, vector-based vaccines, and other novel delivery systems. Additionally, there is a growing focus on developing vaccines that provide broader protection against multiple strains of the Newcastle virus. Leading players in the market are actively involved in launching these new products and technologies. They are collaborating with research institutions, acquiring smaller biotech companies, and investing in their in-house R&D to stay ahead in this competitive market. By introducing these cutting-edge vaccines, these key players aim to cater to the increasing demand for more effective and efficient solutions to safeguard poultry populations from Newcastle disease outbreaks. 

Newcastle Disease Vaccine Market SEGMENTATION

• 

• Request a Free Sample to learn more about this report

• By type

Depending on Newcastle disease vaccine market given are types: live vaccines, killed vaccines. The live vaccines type will capture the maximum market share through 2031.

• By Application

The market is divided into chicken, duck and goose & other based on application. The global newcastle disease vaccine market players in cover segment like Chicken will dominate the market share during 2022-2031.

Driving Factors

"The Growing Demand For Chicken Products And The Ensuing Expansion Of The Poultry Sector Are Fueling The Market Growth"

One driving factor behind the market growth for Newcastle disease vaccines is the increasing demand for poultry products and the consequent expansion of the poultry industry. As the global population continues to grow, there is a rising need for a sustainable and abundant food supply, including poultry meat and eggs. However, Newcastle disease poses a significant threat to poultry flocks, leading to substantial economic losses and food security concerns. To ensure the health and productivity of poultry, farmers and governments are increasingly adopting vaccination as a preventive measure. This surge in demand for Newcastle disease vaccines is propelling the market forward, with manufacturers and researchers focusing on developing more effective and accessible vaccines to meet the growing needs of the industry.

"The Growing Focus On Biosecurity Measures In The Poultry Business Is Another Factor Fueling The Market Expansion For Newcastle Disease Vaccines"

Another driving factor behind the Newcastle disease vaccine market growth is the increasing emphasis on biosecurity measures in the poultry industry. In recent years, there has been a growing awareness of the devastating impact of disease outbreaks on poultry populations and the subsequent economic losses incurred. As a result, poultry farmers and industry stakeholders are placing a greater emphasis on disease prevention and control strategies. Vaccination plays a pivotal role in these efforts, as it provides a proactive and cost-effective means to protect poultry flocks from Newcastle disease. This heightened focus on biosecurity and disease prevention is fueling the demand for Newcastle disease vaccines, creating opportunities for market expansion and the development of innovative vaccine technologies.

Restraining Factors

"The Difficulties In Navigating The Regulatory System And The Lengthy Approval Procedures For Novel Vaccinations Are One Issue Limiting The Market Growth"

One restraining factor affecting the Newcastle disease vaccine market growth is the regulatory challenges and approval processes involved in bringing new vaccines to market. Developing and launching vaccines require rigorous testing and adherence to strict regulatory guidelines to ensure safety and efficacy. Delays in regulatory approvals can slow down the introduction of new and improved vaccines, limiting the options available to poultry farmers. Additionally, stringent regulations in certain regions may create barriers to market entry for vaccine manufacturers. Overcoming these regulatory hurdles requires substantial investments in research, development, and compliance, which can impact the pace of market growth and the availability of advanced vaccine technologies.

Newcastle Disease Vaccine Market Regional Insights

• 

• Request a Free Sample to learn more about this report

"Asia Pacific Will Dominate The Market Since Rapid Advancements In The Poultry Industry And Increasing Awareness Of Biosecurity Measures"

The leading region in the Newcastle disease vaccine market is anticipated to be Asia-Pacific. This region is home to some of the world's largest poultry-producing countries, including China, India, and Indonesia, where the demand for poultry products is continuously increasing due to population growth and changing dietary habits. As a result, there is a heightened need to protect poultry flocks from Newcastle disease outbreaks, leading to a substantial demand for vaccines. Additionally, Asia-Pacific is witnessing rapid advancements in the poultry industry and increasing awareness of biosecurity measures, further boosting the Newcastle disease vaccine market share. These factors position the Asia-Pacific region as a key driver of market growth for these vaccines.

The second-leading region in the Newcastle disease vaccine market is projected to be North America. The region has a well-established poultry industry with a high demand for poultry products, including meat and eggs. Poultry farming in North America faces the ongoing threat of Newcastle disease, necessitating effective preventive measures like vaccination. The region's focus on sustainable agriculture and animal welfare practices further drives the adoption of Newcastle disease vaccines. Additionally, advancements in vaccine technologies and increasing investments in research and development contribute to the growing market share for these vaccines in North America. The region's strong market position underscores its importance in the global Newcastle disease vaccine market.

Key Industry Players

"Key Players Focus on Partnerships to Gain a Competitive Advantage "

Prominent market players are making collaborative efforts by partnering with other companies to stay ahead of the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolios.

List of Market Players Profiled

• Merial (France)
• CEVA (France)
• QYH Biotech (China)
• Ringpu Biology (China)
• Yebio (China)
• Harbin Veterinary Research Institute (China)
• Merck Animal health (U.S.)
• DHN (China)
• Zoetis (U.S.)
• ChengDu Tecbond (China)
• Elanco (Lohmann) (U.S.)
• FATRO (Italy)
• CAVAC (France)
• Vaksindo (Indonesia)

Report Coverage

This research profiles a report with extensive studies that take into description the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, and restraints. This analysis is subject to alteration if the key players and probable analysis of market dynamics change.